Do lipid-lowering agents provide a greater reduction in cardiovascular events among patients with diabetes?
Ann Intern Med
.
2008 Dec 2;149(11):841; author reply 841-2.
doi: 10.7326/0003-4819-149-11-200812020-00023.
Author
Anil K Gollapudi
PMID:
19047040
DOI:
10.7326/0003-4819-149-11-200812020-00023
No abstract available
Publication types
Comment
Letter
MeSH terms
Coronary Disease / prevention & control*
Diabetes Mellitus, Type 2 / complications*
Humans
Hypolipidemic Agents / therapeutic use*
Substances
Hypolipidemic Agents